From the Journals
Latest News
COVID Vaccinations Less Prevalent in Marginalized Patients
Patients in the most unvaccinated group tended to live in places with more ethnic diversity, higher material deprivation, and lower incomes.
From the Journals
Too Little Sleep Raises Health Risks for Teens With T1D
“Sleep may be an important and novel target for improving health in individuals with T1D, particularly when initiated in adolescence or early in...
From the Journals
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...
Latest News
New Trial Deepens Debate Over Late-Preterm Steroids
The early cancellation of a trial in southern India suggests that the use of antenatal steroids to prevent respiratory complications after late-...
Latest News
Antibiotics of Little Benefit in Lower Respiratory Tract Infection
“Patients had unrealistic expectations regarding the duration of LRTI and the effect of antibiotics, which should be the target of antibiotic...
From the Journals
Oncologists Voice Ethical Concerns Over AI in Cancer Care
Researchers ask 204 oncologists from 37 states for their views on the ethical implications of using AI for cancer care.
From the Journals
Less Than 50% of Accelerated Approvals Show Clinical Benefit
Researchers review 46 cancer drugs granted accelerated approvals between 2013 and 2017.
From the Journals
Virtual Reality Brings Relief to Hospitalized Patients With Cancer
Patients were randomized to receive either 10 minutes of immersive VR distraction therapy or 10 minutes of two-dimensional guided imagery...
Latest News
Tuberculosis Prevention Brings Economic Gains, Says WHO
The study “provides strong economic arguments” about the true costs of tuberculosis.
Latest News
Study Shows Nirmatrelvir–Ritonavir No More Effective Than Placebo for COVID-19 Symptom Relief
The drug may not be particularly helpful for patients who are not at high risk for severe COVID-19.